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Alzheimer's Disease (AD)Functional as well as structural alterations in mitochondria size, shape and distribution are precipitating,
early events in progression of Alzheimer's Disease (AD). We reported that a 20–22 kDa NH2-tau fragment
(aka NH2htau), mapping between 26 and 230 amino acids of the longest human tau isoform, is detected
in cellular and animal AD models and is neurotoxic in hippocampal neurons. The NH2htau –but not the
physiological full-length protein– interacts with Aβ at human AD synapses and cooperates with it in
inhibiting the mitochondrial ANT-1-dependent ADP/ATP exchange. Here we show that the NH2htau also
adversely affects the interplay between the mitochondria dynamics and their selective autophagic clear-
ance. Fragmentation and perinuclear mislocalization of mitochondria with smaller size and density are
early found in dying NH2htau-expressing neurons. The speciﬁc effect of NH2htau on quality control of
mitochondria is accompanied by (i) net reduction in their mass in correlation with a general Parkin-
mediated remodeling of membrane proteome; (ii) their extensive association with LC3 and LAMP1 autoph-
agic markers; (iii) bioenergetic deﬁcits and (iv) in vitro synaptic pathology. These results suggest that NH2htau
can compromise the mitochondrial biology thereby contributing to AD synaptic deﬁcits not only by ANT-1
inactivation but also, indirectly, by impairing the quality control mechanism of these organelles.
© 2013 Published by Elsevier Inc.Introduction
Mitochondria dysfunction and clearance are contribution factors to
mammalian aging and to several age-related neurodegenerative disor-
ders named tauopathies, including Alzheimer's Disease (AD) (Batlevi
and La Spada, 2011). Compelling evidence shows a causal link between
mitochondrial dysfunction and impaired synaptic plasticity in ADf 20–22 kDa; ANT-1, Adenine
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vier Inc.pathogenesis at the early preclinical stage (Du et al., 2012; Lee et al.,
2012b; Lin and Beal, 2006). Early deﬁcits of synaptic mitochondria
are indeed detected in mutant APP transgenic mice prior to the ex-
tracellular Aβ deposition (Du et al., 2010) and mitochondria dys-
function in the hippocampal CA3 region precedes the synaptic
deterioration in Tg2576 (APPswe) mice, another FAD (Familiar
Alzheimer's Disease) model (Lee et al., 2012a,b).
Mitochondria exhibit dynamic properties and their homeostasis in a
healthy, functional network is a closely interrelated process that involves
an intimate crosstalk between organelle quality control and autophagy
(Twig et al., 2008). Indeed, as in other cells (Youle and Narendra, 2011),
neuronal mitochondria undergo continuous reshaping by paired ﬁssion/
fusion, transport, biogenesis and selective degradation (mitophagy)
which relies on Parkin-mediated priming followed by their sequestration
into autophagosomes and retro-trafﬁcking along microtubules into peri-
nuclar clusters (mitoaggresomes) (Cai et al., 2012; Sheng et al., 2012; Van
Humbeeck et al., 2011; Van Laar and Berman, 2013; Van Laar et al., 2011;
Wang et al., 2009; Zhu et al., 2012, 2013). All these events are closely
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stantly monitored by every cell in order to maintain a healthy mito-
chondrial population and consequent viability. Moreover, because
of their high energy demands and very polarized morphology, the
proper maintenance of mitochondrial biomass is especially crucial
for survival of post-mitotic neurons that continually modulate
their size and number according to the variable energy demands
and metabolic states in diverse times and/or sub-cellular compart-
ments (Chen and Chan, 2006; Santos et al., 2010; Van Laar and
Berman, 2013; Vives-Bauza and Przedborski, 2011). A pathological
deregulation of mitochondria turnover adversely impinges on their
overall shape, location and metabolic functions so that they are no lon-
ger transported along neuritis and provided to highly-ATP utilization
sites, such as synaptic terminals (Nunnari and Suomalainen, 2012;
Sheng et al., 2012). Consequently, neuronal populations –especially
those with poorly myelinated, long, thin axons located in selectively
vulnerable AD brain areas– are crucially sensitive to improper mito-
chondrial dynamics (Verstreken et al., 2005).
To this regard, a growing body of studies actually shows that,
alongwith an altered trafﬁcking and interorganellar communication,
changes in the quality control of mitochondria –including quality,
number and distribution of their functional population– are causally
correlated with the synaptic demise in vulnerable, affected AD neu-
rons (Campello and Scorrano, 2010; Eckert et al., 2011; Karbowski
and Neutzner, 2012; Palmer et al., 2011; Reddy, 2011; Reddy et al.,
2012; Santos et al., 2010; Sheng et al., 2012). An impaired mitochon-
drial biogenesis, followed by an ensuing deterioration of their bioen-
ergetics (Rintoul and Reynolds, 2010; Sheng et al., 2012; Young-Collier
et al., 2012), and a severe reduction of thesemetabolically-active organ-
elles from distal processes in correlation with their parallel accumula-
tion into neuronal soma are both early events in AD synaptic failure
(Chen and Chan, 2009; Selfridge et al., 2013; Wang et al., 2008a,b,
2009) and, importantly, are detectable prior to any obvious clinical
sign (Stokin et al., 2005). Ultrastuctural changes inmitochondria length
with a dramatic loss in their inner cristae organization, aswell as a dras-
tic reduction in global biomass of these organelles, were early found in
three different FAD transgenic mice mainly at synapses, in correlation
with their energetic failure and prior to the onset of the memory
impairment or of the plaque appearance (Trushina et al., 2012). In AD
patients, a morphometric analysis carried out on affected brain regions
reports a signiﬁcant paucity of mitochondria (Baloyannis, 2006) that
exhibit evident signs of destruction, including rupture of their inner
membrane, lipofuscin-ﬁlled vacuoles, and variable mtDNA (mitochon-
drial DNA) content (Hirai et al., 2001). Functional parameters of mito-
chondria –such as the respiratory capacity and the antioxidant
enzyme activities– are strongly reduced of approximately two-thirds
in AD specimens, almost in part due to a loss of their biomass and/or
to their impaired biogenesis (Young-Collier et al., 2012). Biochemical
unbalance in the expression levels of several mitochondria-shaping
proteins (OPA1, Mfn1/2, Drp1, Fis) or alterations in their posttransla-
tional modiﬁcations are also found in cellular and animal AD models,
as well as in human AD neurons, in association with an excessive frag-
mentation and mislocalization of these organelles, with neuritic bead-
ing and with a loss of dendritic spines (Barsoum et al., 2006; Calkins
and Reddy, 2011, 2011; Cho et al., 2009; Manczak et al., 2011; Tan
et al., 2007; Wang et al., 2008a,b, 2009). In neurons from Tg2576
(APPswe) mice, an impaired mitochondrial biogenesis is accompanied
with amislocalization of these BrdU-positive small, defective organelles
that reside mainly in the cell soma and cannot be transported to axons
and dendrites, hence depriving the nerve terminals of ATP and calcium-
buffering ability (Calkins et al., 2011). Finally an impaired autophagic
ﬂux, including an increased rate of mitochondrial autophagic removal
that leads to selective loss of these organelles –which progressively
lessen in number, volume and cytoplasmic density (Moreira et al.,
2007a,b)– has been described as a prominentADhallmark in vulnerable
hippocampus and prefrontal cortex (Baloyannis, 2006; Young-Collieret al., 2012). Altogether, these ﬁndings point out that pathogenetic
defects in the maintenance of functional mitochondrial biomass are
early events participating in the AD synaptic failure and further bolster
the notion that it may be possible to alleviate the AD bioenergetic
collapse at least in part by interfering with mitochondrial homeostasis
(Bonda et al., 2010). However whether excessive mitophagy, owing to
an uncontrolled quality control pathway of these organelles, is detri-
mental, beneﬁcial, or simply an epiphenomenon and whether it acts
as an early causal event in AD pathogenesis or a late neuroprotective
consequence of other neuropathological insults, remains under intense
debate (Batlevi and La Spada, 2011; Cherra and Chu, 2008; Santos et al.,
2010; Selfridge et al., 2013; Tolkovsky, 2009).
We have previously reported that a 20–22 kDa NH2-tau fragment
(aka NH2htau), mapping between 26 and 230 amino acids of the
human tau40, (i) is neurotoxic in primary cultured neurons (Amadoro
et al., 2004, 2006); (ii) is detected in cellular and animal AD models
(Corsetti et al., 2008) and (iii) is also largely enriched in human mito-
chondria from AD synaptosomes in correlation with the pathological
synaptic changes, with the Aβ multimeric species and with the organ-
elle functional impairment (Amadoro et al., 2010). The NH2htau– but
not the physiological full-length protein– preferentially interacts with
Aβ peptide(s) at human AD synapses and cooperates with it in
inhibiting the mitochondrial ANT-1-dependent ADP/ATP exchange
(Amadoro et al., 2012). In view of that: (i) a structural and functional
impairment of neuronal mitochondria jointly contribute to early synap-
tic alterations in AD (Baloyannis, 2011; Du et al., 2010; Manczak et al.,
2011; Nakamura and Lipton, 2010; Schon and Przedborski, 2011;
Selfridge et al., 2013; Trushina et al., 2012; Wang et al., 2009) and (ii)
pathological Aβ and tau converge in perishing the mitochondria
(Amadoro et al., 2012; Eckert et al., 2011; Quintanilla et al., 2012;
Rhein et al., 2009), we sought to determine whether the NH2htau
can also affect the distribution, shape and size of the mitochondria.
Using both in vivo and in vitro systems, we found out that patholog-
ical NH2htau enhances the mitochondria turnover by harmfully
affecting their fusion/ﬁssion dynamics and their clearance by selec-
tive autophagy.
Results
TheNH2htau fragment early affects the neuronalmitochondriamorphology
in vitro, leading to fragmentation and a net decrease of their biomass
AsNH2htau speciﬁcally interactswithmitochondria in AD (Amadoro
et al., 2012), we sought to investigatewhether its enhanced intracellular
level, as we detected in vivo (Amadoro et al., 2012), inﬂuences themito-
chondrial network integrity in primary cultured neurons.
To this aim, mature hippocampal primary neurons (DIV 15) were
transduced (75% efﬁciency) by adenovirus-mediated infection with
myc-tagged NH2-26–230 tau (myc-NH2htau) and with myc-tagged
empty vector (mock) at low/moderate multiplicity (MOI 50). In agree-
ment with our previous investigations (Amadoro et al., 2004, 2006),
the speciﬁc expression of exogenous myc-NH2htau in cultured neurons
was conﬁrmed to be correlated with a signiﬁcant reduction of neuronal
survival. As assessed byMTT assay and intact nuclei count (seeMaterials
and methods), after 12–16 h post-infection at MOI 50 only 60% of cells
survived while no signiﬁcant difference in viability was found upon
transduction with mock or unrelated LacZ-protein (not shown).
The morphological proﬁle of mitochondria was next examined by
ultrastructural analysis of Transmission Electron Microscopy (TEM). In
control neurons themajority of mitochondria appeared healthy in elon-
gated or tubular shape, along with a well-preserved nuclear envelope
which surrounded a disperse chromatin (Fig. 1A). As previously report-
ed (Frezza et al., 2006), matrices were dark and uniform and the cristae
were homogeneously distributed and highly interconnected, showing
regular intercristal cross-sectional distances. On the contrary, NH2htau-
expressing neurons revealed heterogeneous mitochondrial alterations
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2009). In detail, several of these organelles appeared shorter, globular
and less elongated and sometimes cloudy (Fig. 1A, arrow heads), just
resembling the in vitro deleterious changes due to the neuronal expres-
sion of mitochondria-targeted, toxic, intracellular Aβ (Cha et al., 2012).
Numerous mitochondria appeared roundish and pale with patchy
matrices, sometimes swollen and suffering from the total disap-
pearance of their inner cristae (Fig. 1A, arrows), mimicking the AD
pathological changes found in vivo (Baloyannis, 2006; Hirai et al.,
2001; Moreira et al., 2007a,b). We also detected a dramatic and ab-
errant remodeling in inner membrane cristae revealing enlarged,
dilated electron-transparent space (Fig. 1A, curved arrows), a mito-
chondrial morphology which is evident during the OPA-1/DRP-1
mediated fragmentation of these organelles (Frezza et al., 2006;
Jahani-Asl et al., 2011; Knott et al., 2008) and upon the Parkin-
mediated reshaping/degradation in their outer membrane (Yoshii
et al., 2011). Moreover mitochondria, along with an increased
circularity and a decreased connectivity (see below) which are
both indicators of a reduction in length of these organelles due to
their excessive fragmentation (Dagda et al., 2009, 2011; Xie and
Chung, 2012a,b), showed disorganized cristae (Fig. 1A asterisks)
with an irregular and interrupted intermembrane space. We also
observed discontinuous, fractured outer membranes (Fig. 1A, bold
arrows) which were similar to that visualized during the impaired
turnover of these organelles promoted by the exogenous expression
of α-synuclein (Choubey et al., 2011; Nakamura et al., 2011), another
neuronal protein which also bindsmitochondria and sometimes coexists
in several FADpedigrees at synaptic terminalswith hyperphosphorylated
tau (Muntané et al., 2008). In addition, ultrastructural analysis revealed
that NH2htau-transduced cultures also contained cytosolic vesicles
which appeared to be early autophagosomes enclosing dark mitochon-
dria (Fig. 1A, upper inset), alongwith late/degradative vesicles containing
amorphous, totally and/or partially digested material which are more
comparable to autophagolysomes and/or lysosomes (Fig. 1A, lower
inset; Supplemental Fig. S1). It is also noteworthy that, although the
overall number of mitochondria signiﬁcantly decreasedwith the increas-
ing MOI in our in vitro neuronal model, we found between control and
NH2htau-transduced cultures –even at lowest dosage– a drastic diminu-
tion in density of these organelles, asmeasured bymass (see below), due
to a smaller average size and/or to complete loss in inner structures.
Next, in order to determine whether the changes of mitochondria
integrity (size and shape) as we detected in the NH2htau-expressing
neurons were speciﬁc –i.e. associated to changes of mitochondrial pro-
teome and not of other subcellular compartments– we analyzed the
whole extracts from cultures infected at increasing MOI (25–50–100)
by reacting immunoblots with antibodies against several structural or
soluble mitochondrial proteins located to outer membrane (VDAC1,
Tomm20) (Figs. 1C–D), inner membrane (COXIV, Timm 23, ATP syn-
thase β-subunit) (Figs. 1E, F, G), intermembrane space (cytC) (Fig. 1H)
or to matrix (MnSOD-II, mtHSP60) (Figs. 1I–J). β-III Tubulin was used
as internal loading control (Fig. 1K). Although with different kinetics
and with a relatively parallel pattern discernible during the explicit
induction of mitophagy (Chan et al., 2011; Geisler et al., 2010; Liu
et al., 2012; Narendra et al., 2008), the forced expression of myc-
NH2htau –but not of the mock vector used at high MOI (MOI 100)
(Fig. 1B)– induced at 12 h a decline in the mitochondrial mass even at
lowest-toxicity dosage (MOI 25), as already previously revealed by elec-
tron micrographs (Fig. 1A). Concomitantly, the increasing intracellular
level of NH2htau reduced in a dose-dependent manner a large number
ofmitochondrialmarkers, thus lessening the content of these organelles
per cell over controls (Chan et al., 2011; Liu et al., 2012; Van Humbeeck
et al., 2011;Wang et al., 2011). At 12h post-infection, such decrease did
not involve mtHSP60 (Fig. 1J) and F1β (not shown) whose delayed
decline –as previously reported (Chan et al., 2011; Wang et al., 2011)–
occurs only at later times and more slowly after mitochondrial stress.
Actually, in line with other reports (Chan et al., 2011; Wang et al.,2011), a more pronounced degradation of all the above mentioned
mitochondrial proteins (including HSP60 and F1β) was observed in
our in vitro system at prolonged times of incubation (18–24h). Densito-
metric quantiﬁcation of results is shown in Fig. 1L, by normalizing
values on the β-III tubulin signal to establish the relative abundance of
mitochondrial proteins per overall cell protein content. Importantly,
no difference was contextually found in the expression levels of non-
mitochondrial markers such as for endoplasmic reticulum (calnexin)
(Fig. 1M), for Golgi complex (α-58K) (Fig. 1N), and for peroxisomes
(catalase) (Fig. 1O) that remarkably use the same machinery of
ﬁssion as the mitochondria (Koch et al., 2010), or for axonal trans-
port motors (kinesin/dynein) that are involved in the organelle
delivery (Figs. 1P-Q), pointing out a selective process which drives
the mitochondria removal in these neuronal cultures. Moreover,
when expressed at similar low level (MOI 50) of toxic NH2htau frag-
ment, the full-length human myc-tau 1–441 (htau40) did not affect
the neuronal survival (Amadoro et al., 2006) and did not cause the
mitochondrial content decline (see below, Fig. 5), further strength-
ening that the event was also speciﬁc and not simply an artifact of
overexpression of myc-tagged tau proteins. Likewise, signiﬁcant
change neither in viability (Amadoro et al., 2006) nor in mitochon-
drial mass (not shown) was found upon adenovirus-mediated trans-
duction of primary neuronal cultures with unrelated LacZ-protein.
To ascertain whether the almost general decrease in the amount of
mitochondrial proteins detected by Western blotting was due to an
actual decrease in mitochondrial mass, the quantity of mitochondria
was further estimated in these neuronal cultures transduced at MOI
50 by two different methodologies. One was spectrophotometric mea-
surement of the activity of citrate synthase (CS), amitochondrialmatrix
enzyme of the Krebs cycle, which remains highly constant in these
organelles and is considered to be a reliablemarker of their intracellular
content (Barrientos, 2002; Choubey et al., 2011; Pallotti and Lenaz,
2001; Rustin et al., 1994; Zeviani et al., 1991). The other method was
the estimation of their DNA amount (mtDNA), using etoposide as
positive internal control, by real-time PCR on mitochondrial NADH-
ubiquinone oxidoreductase chain 2 (mtND2) gene (expressed as
mtDNA/nuclear DNA ratio by normalizing to that of hTERT genomic
DNA) (Fu et al., 2008). As shown (Fig. 1R), a signiﬁcant decrease of
about 50% in CS activity (normalized by the total homogenate pro-
teins content) was found in NH2htau-infected hippocampal cultures
when compared to mock-infected control neurons. Consistently and
in agreement with its speciﬁc effect on decline of mitochondrial pro-
teins observed by our previous Western blotting (Figs. 1C–K), the
NH2htau fragment –but not full-length human tau protein expressed
at similar level– induced a substantial parallel decrease of about 35–
40% in the mtDNA copy number (Fig. 1S) in human SY5Y, a neuronal
cell-line undergoing apoptosis with endogenous production of the
NH2htau fragment (Corsetti et al., 2008) and properly used to assess
the mitochondrial DNA content in comparison with post-mitotic
neurons provided (Fu et al., 2008).
Collectively these ﬁndings suggest that the moderate and early ex-
pression of NH2htau fragment in neurons is sufﬁcient (i) to evoke
changes in mitochondria morphology by inducing shorter organelles
that undergo enlargement, cristae disorganization and complete loss
of inner structures and (ii) to cause a frank and speciﬁc decrease of mi-
tochondriamass, bothmirroring the pathogenetic in vivo changes found
in AD brains (Baloyannis, 2006; Moreira et al., 2007a,b; Wang et al.,
2008a, 2009; Young-Collier et al., 2012).
Defective mitochondria are redistributed in soma and reduced in distal
neuritis in NH2htau-expressing neurons
Pathological changes in mitochondria morphology/integrity can
negatively impact on their proper transport along neuritis (Nunnari
and Suomalainen, 2012; Sheng et al., 2012; Xie and Chung, 2012). Like-
wise, the Pink 1/Parkin pathway directly participates in regulating the
492 G. Amadoro et al. / Neurobiology of Disease 62 (2014) 489–507distribution of damaged mitochondria during mitophagy by arresting
their anterograde movements along axons (Cai et al., 2012; Kane and
Youle, 2011a,b; Liu et al., 2012; Wang et al., 2011).
In viewof theseﬁndings, we set out to examine the subcellular local-
ization of mitochondria in NH2htau-transduced neurons turning to two
different –but complementary– experimental approaches. We ﬁrst
explored the mitochondrial network with MitoTracker CMxRos dye
(mitochondrial membrane potential-dependent) (Cho et al., 2012;
Trushina et al., 2012) because (i) the morphology of these organelles
remains intact after the cell ﬁxation procedure (Zhu et al., 2011; Zhu
et al., 2012) and (ii) the accumulation of this functional probe into the
lipid environment of mitochondria is driven in live cells by their mem-
brane potential, so that its ﬂuorescence intensity indirectly also indi-
cates the energetic state of these organelles. As shown in Figs. 2A–B, at
12 h post-infection (MOI 50) we found that in control neurons mostA) B)
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NH2 htaumitochondriawere energized, respiration-competent and appeared as a
very thin, interconnected, tubular network that homogeneously cov-
ered the soma and neuronal processes. On the contrary, the moderate
expression of NH2htau in neuronal cultures caused an evident and net
decrease in proportion of these polarized, healthy organelles –that is
consistent with our previous TEM analysis (Fig. 1A)– along with a dras-
tic alteration in their transport/subcellular localization (Figs. 2A–B,
arrow heads). In detail, dying neurons exhibited “trafﬁcking jams”
of normal as well as more globular degenerating mitochondria that
appeared unevenly distributed along the neuritis (bold arrows),
thus resembling the “beads-on-string” distribution pattern (Cai
et al., 2012; Trushina et al., 2012; Vande Velde et al., 2011). In addi-
tion, as typically discernible during Parkin-mediated selective
mitophagy in neurons (Cai et al., 2012; Van Humbeeck et al., 2011),
a large part of these organelles were clustered around the nucleus,
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to axons and dendrites hence depriving the distal nerve terminals of
ATP and calcium-buffering capacity (Calkins et al., 2011). This intracellu-
lar pattern was very similar to that visualized in NH2htau-infected cul-
tures after immunocytochemistry with GRP75/mortalin/PBP74/mthsp70
(glucose-regulated protein 75), another non-functional (i.e. membrane
potential-independent) mitochondrial marker that labels the whole
population of these organelles (Fig. 2C). Furthermore this segregation
was also reminiscent of our in vivo studies carried out on degenerating
AD neurons, whose mitochondria are perinuclear and express a high en-
dogenous level of NH2htau fragment (Amadoro et al., 2012).
Next we quantiﬁed the changes inmitochondria distribution detect-
ed in control and NH2htau-expressing cultures, by measuring the
subcellular occupancy of these organelles in somatic and in neuritic
compartments. Morphometric analysis of the MitoTracker red ﬂuo-
rescence intensity shows that these organelles (i.e. energized mito-
chondria) diminished in neuronal processes (−140%) (Fig. 2E) in a
larger extent than in the soma (−60%) (Fig. 2D) of NH2htau-expressing
cultures if compared to controls (Student's t test *pb0.05). Consistently,
the percentage of cellular area occupied by MitoTracker red-positive
mitochondria shows greater decrease in neuronal processes (−400%)
(Fig. 2G) than in soma (−220%) (Fig. 2F) of NH2htau-expressing neu-
rons if compared to controls (Student's t test *pb 0.05). Similar results
(not shown) were obtained by quantiﬁcation of BrdU-labeled mito-
chondria with newly-synthesized mtDNA (Calkins et al., 2011).
Further, as the reduction in mitochondria interconnectivity and the
increase in their circularity are typically used to evaluate fragmentation
of the mitochondrial network and as mitophagy indexes (Dagda et al.,
2009), we performed a morphological quantiﬁcation of these two
parameters onGRP75-positive organelles. Evaluation of interconnec-
tivity (area/perimeter ratio) (Fig. 2H) and elongation (major/minor
axis ratio) (Fig. 2I) on GRP75-positive mitochondria shows a signif-
icant reduction (−871% and −393% respectively) in NH2htau-
expressing cultures when compared to controls (Student's t test
**p b0.01).
These ﬁndings point up that NH2htau fragment is sufﬁcient to evoke
drastic in vitro changes not only inmorphology but also inmitochondria
localization, leading to a peri-nuclear accumulation of these defective
organelles and in parallel to their uneven coverage in distal neuronal
processes, as evident during the explicit induction of selective
mitophagy in cultured neurons (Cai et al., 2012) or as detectable in
AD brains (Amadoro et al., 2012; Wang et al., 2009).Fig. 1. NH2htau-expressing neurons exhibit early alterations in morphology of mitochondria w
mature hippocampal primary neurons (DIV 15) adenovirally transduced at MOI 50 with myc-t
and examined at 12–16h post-infection. The greatmajority ofmitochondria in the control group
cristae. On the contrary, organelles in myc-NH2htau-expressing neurons (myc-NH2htau pane
(curved arrows) or disorganized (asterisks) inner membrane cristae. Mitochondria “discontinu
of the inner cristae (arrows) were also evident in NH2htau-expressing neurons. Ultrastructural
the initial stages of mito-autophagosome digestion and localized around an altered nuclear env
rial (lower inset), jointly indicating the complete and efﬁcient autophagic removal of organell
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tochondrial proteins located to outer membrane (VDAC1, Tomm20) (C–D), inner membrane (
matrix (MnSOD-II, mtHSP60) (I–J) are shown. The dose-dependent expression of myc-tagged N
tometric analysis is shown (L) bynormalizing the immunoreactivity protein intensity on theβ-I
proteins. Values are means of ﬁve independent experiments and statistically signiﬁcant diff
***p b 0.0001 versusmock). (M to S) Western blotting analysis (n= 5) on total protein extract
(25–50–100) with myc-NH2htau and with mock control (MOI 100) and examined at 12 h pos
markers such as for endoplasmic reticulum (calnexin) (M), for Golgi complex (α-58K) (N), fo
and dynein p150 glued (P–Q, respectively) or for two autophagic markers Microtubule-Associa
tively). (T) Estimation of mitochondrial mass carried out at 12 h on rat hippocampal neurons i
activity of citrate synthase expressed as nanomoles per minute per milligram of protein. Value
calculated by unpaired-two tailed Student's t test (***p b 0.0001 versus mock). (U) Quantitat
transduced human SH-SY5Y neuroblastoma cells, by measuring the content of a speciﬁc mitoch
scriptase (hTERT) genomic DNA was used to normalize and 10 μM etoposide (not shown) was
tically signiﬁcant differences were calculated by unpaired-two tailed Student's t test (*p b 0.05Parkin-driven changes in the levels of mitochondria reshaping proteins
OPA1 and Mfn1/2 also occur in NH2htau-expressing neurons
The E3 ubiquitin ligase Parkin plays a critical role in regulating the
quality control of mitochondria in neurons (Karbowski and Youle,
2011; Sheng et al., 2012; Vives-Bauza and Przedborski, 2011; Vives-
Bauza et al., 2010; Ziviani and Whitworth, 2010), by intersecting the
dynamics of these organelles and then by stimulating their selective
autophagic degradation (Cai et al., 2012; Joselin et al., 2012; Tanaka
et al., 2010; Van Humbeeck et al., 2011). As well as for fragmentation
and for arrest of motility, it has been reported that Parkin can facilitate
the selective clearance of mitochondria by promoting the rupture,
ubiquitination and proteasome-dependent degradation (Ashraﬁ and
Schwarz, 2012) in several membrane-bound proteins of these organ-
elles —such as GTPases Optic Atrophy 1 (OPA1) (Chan et al., 2011;
Yoshii et al., 2011) and Mitofusin 1/2 (Mfn1/2) (Glauser et al., 2011;
Ziviani and Whitworth, 2010).
In view of these considerations, we moved about ascertaining
whether the NH2htau-induced mitochondrial loss was associated to a
Parkin-dependent targeting/remodeling of mitochondrial membrane
proteome and/or to changes in the expression of reshaping proteins
with nonrespiratory functions but which more directly control the
integrity of these organelles in neurons (Trushina et al., 2012; Wang
et al., 2009). To this aim, the pattern of several key proteins for mito-
chondrial ﬁssion (i.e. Drp1) and fusion (i.e. OPA1, Mfn1/2) along with
the upstream Pink 1/Parkin pathway (Glauser et al., 2011; Springer
et al., 2011; Wang et al., 2011; Yu et al., 2011) was also analyzed in
our in vitro neuronal model. By Western blotting analysis on total
protein extracts, we found that the graded increase of myc-NH2htau
intracellular level was accompanied at 12 h post-infection in primary
hippocampal cultures by a modulation in processing/stability towards
full-length high molecular weight form (63 kDa) of Pink 1 (Fig. 3A), a
Ser/Thr kinase known to cooperate with Parkin in promoting the selec-
tive removal of mitochondria in neurons (Joselin et al., 2012; Wang
et al., 2011) during the explicit induction of mitophagy (Ashraﬁ and
Schwarz, 2012). Remarkably, the myc-tagged NH2htau increased the
Pink 1 66/55 kDa ratio at mitochondria (Fig. 3A) by favoring the
steady-state accumulation of 66-kDa full-length form over the 53 kDa
lower one, the latter is localized in the inner membrane fraction and
represents a mature form (i.e. avoided of the mitochondrial targeting
sequence) that does not recruit Parkin (Jin et al., 2010). On the contrary,
inmock-infected neurons, the 66-kDa full-length Pink 1 –that is insteadith selective and net removal of these organelles. (A) Electron microscopy images (TEM) of
agged NH2-26–230 tau (i.e.myc-NH2htau) and with myc-tagged control vector (i.e.mock)
(mockpanel) had a typical ﬁlamentous-elongatednetworked patternwithwell-organized
ls) showed mainly round-shaped, fragmented morphology (arrow heads) with enlarged
ous”with fractured outer membranes (bold arrows) or “ghost”with a total disappearance
analysis by TEM also demonstrated electron-dense mitochondria (upper inset), resembling
elopes, along with larger electron-translucent autolysosomes with partially digested mate-
es. The right upper panels show enlarged views of the boxed area. Scale bar 1 μm. (B to L)
ns (DIV 15) adenovirally transduced at increasing MOI (25–50–100) with myc-NH2htau
ive densitometric graphs revealing an extensive dose-dependent proteolysis of several mi-
COXIV, Timm 23, ATP synthase β-subunit) (E, F, G), intermembrane space (cytC) (H) or to
H2htau was checked (B) and β-III tubulin was used as internal loading control (K). Densi-
II tubulin signal to establish the relative abundance ofmitochondrial proteins per overall cell
erences were calculated by unpaired-two tailed Student's t test (*p b 0.05; **p b 0.001;
s from hippocampal primary neurons (DIV 15) adenovirally transduced at increasing MOI
t-infection. Immunoblots were probed with speciﬁc antibodies against non-mitochondrial
r peroxisomes (catalase) (O), for two axonal transport motors Kinesin High Chain (KHC)
ted Protein 1A/1B-light chain 3 (LC3) and NBR1 (neighbor of BRCA1 gene 1) (R–S, respec-
nfected with of myc-tagged vectors (MOI 50) by spectrophotometric measurement of the
s are means of ﬁve independent experiments and statistically signiﬁcant differences were
ive real-time PCR determination of mitochondrial DNA (mtND2DNA) at 12 h on MOI 50-
ondrial gene NADH-ubiquinone oxidoreductase chain 2. Human-Telomerase Reverse Tran-
included as internal control. Values are means of two independent experiments and statis-
versusmock).
Fig. 2. Fragmented and defective mitochondria accumulate in the soma and in the proximal dendritic regions in NH2htau-expressing neurons. (A to C) The sub-cellular localization ofmi-
tochondria was assessed at 12 h post-infection (MOI 50) in mock- and myc-NH2htau-expressing hippocampal cultures by live-staining (red channel) with MitoTracker CMxRos (mem-
brane potential-dependent) (A–B) and by immunoﬂuorescence (green channel) with GRP75 (glucose-regulated protein 75) (C), two mitochondrial markers that label the polarized
and whole organelle population respectively. Nuclei (blue channel) were stainedwith DAPI. A DIC (Differential Interference Contrast) light transmitted channel was acquired to visualize
neuritic structures (B). Note that fewpolarizedmitochondria aremainly clustered in somatodendritic regions of NH2htau-expressing neuronswhile amore uniformnetwork of energized,
respiration-competent and interconnected organelles is clearly detectable in healthy, control cultures. (D–E) Estimation of theMitoTrackermean pixelﬂuorescence intensity in cell bodies
(D) and in neuritis (E) between control (white column) and NH2htau-infected (black column) cultures. Values are means of three independent experiments and statistically signiﬁcant
differenceswere calculated by unpaired-two tailed Student's t test (*pb0.05 versusmock). (F–G) Estimation of the proportion of cellular area occupied byMitoTracker-positivemitochon-
dria (ratio between the area occupied by the ﬂuorescence and the area sampled) in cell bodies (F) and in neuronal processes (G) between control (white column) and NH2htau-infected
(black column) (unpaired-two tailed Student's t test *p b 0.05). (H–I) Quantiﬁcation, on GRP75-positive mitochondria, of interconnectivity (area/perimeter ratio; H) and elongation
(major/minor axis ratio; I) between control (white column) and NH2htau-infected (black column) cultures. Values are means of three independent experiments and statistically signif-
icant differences were calculated by paired-two tailed Student's t test (**p b 0.01 versusmock). Scale bar: MitoTracker=20 μm; DAPI-GRP75=15 μm.
494 G. Amadoro et al. / Neurobiology of Disease 62 (2014) 489–507speciﬁcally located on the outer mitochondrial membrane where it can
recruit Parkin (Jin et al., 2010; Narendra et al., 2010)– was only faintly
detected. Furthermore, a signiﬁcant depletion in immunoreactivity of
long OPA1 isoform (Fig. 3B) and Mfn1 and Mfn2 (Figs. 3C–D) was also
detected already after the moderate myc-NH2htau-overexpression
(MOI 25), suggesting that the low-toxicity level of intracellular NH2htau
is sufﬁcient to perturbate the mitochondria integrity at least in part by
promoting a non-fusing state of these organelles, as previously de-
scribed to occur in vivo in affected AD neurons (Wang et al., 2009).
Notably, as in mitophagy induced by Parkin-mediated remodeling of
outer membrane proteome (Chan et al., 2011), the graded intracellular
expression of NH2htau destabilized in a dose-dependent way the long
OPA1 isoform (Fig. 3B) which disappeared more rapidly than the short
one that, on the contrary, is more resistant to degradation (Song, et al.,
2007). The progressive decline of the OPA1 steady-state level detected
in NH2htau-expressing neurons with the increasing MOI not only sup-
ported our previous ultrastructural ﬁndings (Fig. 1A and Supplemental
Fig. S1), showing that a much larger number of small and rounded
mitochondria was found in these cultures than in control ones, but
also aligned with the fact that an up-regulation of OPA1 expression
level in neurons is per se sufﬁcient to restoremitochondrialmorphology
(Jahani-Asl et al., 2011) while a depletion of its immunoreactivity is
linked to a diminished fusion capacity of these organelles (Twig et al.,
2008). Moreover, consistently with others (Tanaka et al., 2010) and in
a similar way of mutant A53T α-synuclein that also binds to mitochon-
dria and promotes their ﬁssion through a Drp-1 independent pathway
(Nakamura et al., 2011; Xie and Chung, 2012), no signiﬁcant change
was found in the relative total level –or in its Ser616 phoshorylation(not shown)– of Drp1 (dynamin-related protein 1), a mitochondrial-
ﬁssion GTPase known to promote fragmentation of these organelles in
AD (Wang et al., 2009). Densitometric quantiﬁcation of results is shown
(Fig. 3F), obtained by normalizing on mtHSP60 intensity (Fig. 3E) to
establish the relative abundance per mitochondrion.
Next we checked whether the Parkin translocation to mitochondria
–which triggers mitophagy in primary cortical neurons in response to a
variety of mitochondrial damaging agents (Joselin et al., 2012)– also oc-
curred in our 12h-infected cultures. As shown by biochemical fraction-
ation of cytosolic/mitochondrial proteins (Figs. 3G–H–I–L), not only did
we conﬁrm that the largest part of overexpressed myc-NH2htau
(MOI 50) was localized at mitochondria in tau-transduced neurons
(Amadoro et al., 2010; Corsetti et al., 2008), but also we found out
that its distribution to these organelles was paralleled by that of endog-
enous Parkin, which was indeed recovered mainly in mitochondria-
enriched fractions and nearly excluded from corresponding cytosolic
compartments. Conversely, we did not ﬁnd any signiﬁcant recruitment
of endogenous Parkin at mitochondria in mock-cultures at 12 h post-
infection even after treatment for 5 h with 10 μM FCCP (carbonyl cya-
nide 4-(triﬂuoromethoxy)phenylhydrazone), a protonophore which is
known to lead to fragmentation of these organelles and to their selec-
tive removal by autophagy in primary neurons only after prolonged
times (18–24h) of incubation (Cai et al., 2012).
Altogether, these ﬁndings suggest that the inverse correlation
detected in NH2htau-expressing neurons between the recruitment of
endogenous Parkin to mitochondria and the downregulation in the ex-
pression levels of their reshapingproteinsMfn1,Mfn2, OPA1 –justmim-
icking the parallel changes occurring in AD neurons (Wang et al.,
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Fig. 3.Mitochondrial Parkin translocation and perturbations inmitochondria dynamics also occur in NH2htau-expressing neurons. (A to F) Representative blots (A–E) ofWestern blotting
analysis (n=3) on total protein extracts fromhippocampal primary neurons (DIV 15) adenovirally transduced at increasingMOI (25–50–100)withmyc-NH2htau andwithmock control
(MOI 100) and examined at 12 h post-infection. The expression pattern of several key proteins controlling mitochondria turnover was assessed by probing immunoblots with speciﬁc
antibodies against Pink 1 (A), and two pro-fusion proteins OPA1 (B) and Mfn1 and Mfn2 (C–D). Densitometric quantiﬁcation of results was obtained (F) by normalizing onmtHSP60 in-
tensity (E) to establish the relative proteins abundance permitochondrion. Values aremeans of three independent experiments and statistically signiﬁcant differences were calculated by
unpaired-two tailed Student's t test (***pb0.0001 versusmock). (G to L) Representative blot ofWestern blotting analysis (n=2) on equal proteins amount of cytosolic andmitochondrial
fractions (40 μg) from hippocampal primary neurons (DIV 15) adenovirally transduced for 12h with myc-NH2htau (MOI 50) and with mock control (MOI 100)—in the absence or in the
presence of 10 μM FCCP (carbonyl cyanide 4-(triﬂuoromethoxy)phenylhydrazone) added to cultures for the last 5 h. The co-distribution of overexpressed myc-NH2htau and endogenous
Parkin atmitochondria in infectedneuronswas ascertained byprobingwithmyc-tag antibody (H) andwithmouse Parkin (clone Park8) (G). The efﬁciency and thepurity ofmitochondrial
preparationwere checkedbyprobing fractionatedprotein fractionswith several speciﬁc antibodies reactingwith cytoplasmatic (copper/zinc–Cu/Zn–SODI) (L) andmitochondrialmarkers
(mtHSP60) (I).
495G. Amadoro et al. / Neurobiology of Disease 62 (2014) 489–5072009)–may account for the generation of more roundish, ruptured and
disorganized organelles relative to the controls (Fig. 1A) and for the fa-
cilitation of mitophagy ﬂux (Ashraﬁ and Schwarz, 2012; Glauser et al.,
2011; Joselin et al., 2012).
Mitochondrial autophagy is increased in NH2 human tau-expressing
neurons
Next,we ascertainedwhether theNH2htau-induced abnormal clear-
ance ofmitochondria that leads in neurons to reduction of their biomass
occurred via the autophagy–lysosomal pathway, as previously sug-
gested in Figs. 1R–S. The autophagic nature of this event was tested by
confocal analysis on MOI 50-infected hippocampal cultures at 12 hafter double immunoﬂuorescence with cytC (green) and LC3 (red),
two markers used routinely to detect activation of mitophagy in neu-
rons (Cai et al., 2012; Van Humbeeck et al., 2011). CytC is a dynamicmi-
tochondrial marker localized to intermembrane space of these
organelles and its cytosolic release is a very late event occurring during
excitotoxic death (Cheung et al., 2005; Cregan et al., 2002), as previous-
ly reported to occur after the exogenous expression of NH2htau in neu-
rons (Amadoro et al., 2006). LC3 (Microtubule-Associated Protein 1A/
1B-light chain 3) is a known autophagic indicator that localizes in its
lipidated form (LC3II) to autophagosomal membranes (Klionsky et al.,
2008, 2012). As shown in Fig. 4A, NH2htau-expressing neurons were
endowed with a large number of LC3-stained puncta colocalizing with
cytC-positive fragmented mitochondria that –as we have previously
496 G. Amadoro et al. / Neurobiology of Disease 62 (2014) 489–507detected (Figs. 2A–B)– were clearly accumulated in somatodendritic
compartment (mito-aggresomes). No overlapping labeled dots (yel-
low) were found in mock-infected neurons that showed a healthy and
even distributed cytC-positive mitochondrial network along with a dis-
perse and nearly undetectable LC3 staining in the cytoplasm. It is note-
worthy that under physiological conditions, axons and dendrites are
almost devoid of autophagic vacuoles and lysosomes, since neurons
are particularly vulnerable to developing autophagic stress (Chu,
2006). In healthy neurons autophagosomes are rarely observed, likely
due to their high basal autophagic rates compared to other cell types
so that the autophagic material is rapidly degraded (Yue et al., 2009),
and LC3 exists under normal condition predominantly in its soluble
LC3-I form which shows a faint and diffuse staining (Wang et al.,
2006). Consistently,morphometric analysis of autophagic vesicles num-
ber showed a 43% increase in the number of LC3-positive mitophagic
bodies (tau-infected versus mock-infected: Student's t test *p b 0.05)
and their relative diameter similarly raised to 52% (tau-infected versus
mock-infected: Student's t test *p b 0.05). These data put forward that
the expression of NH2htau-truncated formwas sufﬁcient to signiﬁcantly
increase the autophagic neuronal phenotype, alike another COOH-
derived (Asp 421) caspase-cleaved tau fragment (Dolan and Johnson,
2010). In addition, the number of cytC-positive fragmented mitochon-
dria that were also labeled by LC3 enhanced to 74% (tau-infected versus
mock-infected: Student's t test **pb0.01), thus conﬁrming that these
organelles were mainly degraded via the autophagy–lysosomal
pathway in NH2htau-expressing neurons. Remarkably, the possible
activation of non selective-autophagy was ruled out by colocalization
analysis of cytC/LC3 double staining performed with the Pearson's
correlation coefﬁcient (Zinchuk and Grossenbacher-Zinchuk, 2009)
that estimated an average value (Rr) of 0.89 ± 0.02 in NH2htau-
infected cultures and of 0.35 ± 0.27 in controls (Student's t test
**pb0.01), indicating a high and low degree of codistribution respec-
tively. Of note the Manders' coefﬁcients showed a medium-high de-
gree of overlap between cytC and LC3 signals in mock-infected
cultures (LC3/cytC = 0.73 ± 0.02; cytC/LC3 = 0.68 ± 0.07) which
signiﬁcantly (Student's t test **p b 0.01) increased nearly to 100% (LC3/
cytC=0.98± 0.01; cytC/LC3=0.97±0.01) of overlap in NH2htau-
infected. Notably these ﬁndings suggested that in mock-conditions
there were basal co-expression levels of LC3/cytC markers that
were not correlated –as indicated by the low Pearson's coefﬁcient–
which, on the contrary, appeared to increase and correlate after
NH2htau-infection. Importantly, the NH2htau overexpression also
produced a dramatic increase in dotted labeling of lysosome marker
LAMP-1 that –consistent with the preferential subcellular localiza-
tion of mature and acid lysosomes in neurons (Cai et al., 2012)–
was detected mainly in the perinuclear area and partially colocalized
with Tomm20-positive roundish mitochondria (Fig. 4A′), thereby
suggesting that a proportion of defective mitochondria were efﬁ-
ciently removed by lysosomes. On the contrary, in mock-infected
neurons, the LAMP-1 staining appeared as small puncta that did
not colocalize with Tomm20-positive elongated mitochondria. The
complete and preferential clearance of these organelles occurring
along the autophagic ﬂux in NH2htau-expressing neurons was also
demonstrated by ultrastructural analysis by electron microscopy
which revealed the presence of perinuclear electron-dense mitochon-
dria (Fig. 1A, upper inset), just resembling the initial stages of mito-
autophagosome digestion/maturation (Viscomi et al., 2012). Early/
degradative, doublemembrane-limited vesicles containing cytoplasmic
material and/or organelles at various stages of degradation were also
found along with more mature “empty” late/degradative vesicles
(Fig. 1A, lower inset; Supplemental Fig. S1). These vesicular proﬁles
(Boland et al., 2008) indicated that the fusion of autophagosomes
with late endosomal and lysosomal compartments was efﬁcient in our
in vitroneuronalmodel. In linewith theseﬁndings,we evaluated the co-
efﬁcient of variation (CV = SD/mean) for LC3 ﬂuorescence intensity
present in the neuronal bodies which has previously been used as anindex of the compartmentalization/diffusion state of a protein in the cy-
tosol and it is considered a reliable measure of the endogenous level of
autophagic activity (Campanella et al., 2009; Klionsky et al., 2012). The
ﬂuorescence CV (Fig. 4A′) was of 0.69 for LC3 in the NH2htau-
expressing neurons, demonstrating a net shift towards amore compart-
mentalized cytosolic state of this autophagic marker when compared to
the corresponding lower and roughly similar values estimated in the
mock ones (0.45 for LC3). For LAMP1, due to the variability in the size
and number of positive lysosomial organelles, which could affect the
evaluation of the ﬂuorescence intensity (Falcón-Pérez et al., 2005) an
additional analytical indexwas also carried out. To estimate the concen-
tration of LAMP1 staining, the size and the mean ﬂuorescence intensity
of the ﬂuorescent structures were taken into account. Again, in the
NH2htau-expressing neurons a signiﬁcant 71% increase in respect of the
control ones was observed (Fig. 4A′). The ﬁndings that in NH2htau-
expressing the analytical values were signiﬁcantly (Student's t test
*pb0.05) higher when compared to control ones for both early and late
autophagicmarkers supported the notion that a removal ofmitochondria
occurred up to theﬁnal steps in these cultures, according to the increased
expression level of exogenous NH2htau.
As known, during autophagy, soluble proLC3 is proteolysed to
generate its cytosolic form (LC3-I) which is conjugated to phospha-
tidylethanolamine to form LC3–phosphatidylethanolamine conju-
gate (LC3-II) that, eventually, is recruited to autophagosomal
membranes. Therefore the mobility shift of LC3-II –which exhibits
a faster migration by SDS-PAGE– as well as the increased conversion
ratio LC3II/LC3I is frequently used to assess the induction of autoph-
agy in neurons (Kabeya et al., 2000; Klionsky et al., 2008, 2012;
Viscomi et al., 2012). Moreover, an increased autophagic ﬂux leads
to an augmented elimination of p62/SQTM-1 (Sequestosome-1)
and NBR1 (neighbor of BRCA1 gene 1) (Bjørkøy et al., 2005; Kirkin
et al., 2009; Komatsu et al., 2007; Viscomi et al., 2012), two proteins
that interact with LC3-II and thus become incorporated into the
autophagosomes and subsequently degraded in lysosomes (Yue et al.,
2009). Consistently with our morphological observations, the autopha-
gy activation upon overexpression ofmyc-NH2htauwas further validat-
ed by the fact that the diminution in level of p62/SQTM-1 and NBR1
immunoreactivity was contextually correlated in these neurons by an
inverse elevation in LC3-II/LC3-I ratio (Figs. 4B–C–D), as shown by
Western blotting on total protein extracts and relative densitometric
analysis (Fig. 4F). Notably, no change or even a modest and transient
increase in the amount of p62/SQTM-1 has also been described in
conditions where there is an augmented autophagic ﬂux (Klionsky
et al., 2012). Finally, in agreement with others (Chu et al., 2007; Zhu
et al., 2007) reporting that mitophagy can also occur independently of
Beclin-1, no signiﬁcant difference (not shown) was found in level of
this key pro-autophagic protein whose decline was associated with
aging and AD pathogenesis (Pickford et al., 2008). Although an inverse
correlation between the increase in LC3-II immunoreactivity and the
decrease in p62/SQTM-1 and in NBR1 is largely considered a reliable
method to monitor the endogenous autophagic ﬂux (Klionsky et al.,
2008, 2012), we decided to measure it by an alternative and otherwise
exact experimental procedure, such as by inferring the LC3-II turnover
in the presence and in the absence of agents that eventually neutralize
the pH lysosomal degradation (Klionsky et al., 2008, 2012). To this
aim, we quantiﬁed by Western blotting analysis and relative densito-
metric analysis (Figs. 4H–K), the difference in the intensity level of
LC3-II in the presence and in the absence of baﬁlomycin A1 (BAF-A1,
50 nM) and chloroquine (CQ 25 μM), by comparing NH2htau-
expressing neurons to control ones. BAF-A1 is a cell-permeable, selec-
tive inhibitor of vacuolar-type (v-type) H+ATPase while CQ is another
alkalizing reagent –such as NH4Cl– used to raise the lysosomal pH
which leads to inhibition of both fusion of autophagosome with
lysosome and lysosomal protein degradation. Under basal conditions
NH2htau-expressing neurons showed, relative to control ones, an in-
creased LC3-II level which –when the lysosomal degradation was
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Fig. 4. The NH2htau fragment accelerates the autophagic ﬂux of mitochondria (mitophagy). (A–A′) In A: Confocal microscopy analysis of double immunoﬂuorescence for cytC (green channel)
and LC3 (red channel), carried out on primary hippocampal cultures at 12 h post-infection (MOI 50) with mock- and myc-NH2htau vectors. Nuclei were stained with DAPI (blue channel).
LC3immunoﬂuorescence is very faint in mock-treated group while numerous labeled LC3 stained vesicles –which were also intensely positive (colocalized) for cytC–were observed in myc-
NH2htau neurons. Morphometric graphs show the diameters (expressed in μm) and the number of autophagic vesicles (LC3 positive) between control- (white column) and NH2htau-
infected neurons (black column). Plot of the spatial proﬁle (white line in the LC3/cytC merged image) of pixel intensity for cytC (green line) and LC3 (red line) indicates the net increase of im-
munoreactivity in correspondence of three double-labeled vesicles. Values aremeans of three independent experiments and statistically signiﬁcant differenceswere calculated by unpaired-two
tailed Student's t test (*p b 0.05 versusmock). In A′: Double immunoﬂuorescence analysis with lysosome marker LAMP-1 (green channel) and mitochondrial marker Tomm20 (red channel),
carried out on primary hippocampal cultures at 12h post-infection (MOI 50) withmock- andmyc-NH2htau vectors. Some fragmented TOM20-positive mitochondria (red channel) andmany
LAMP1-positive vesicles (green channel) were colocalized (yellow dots) and accumulated in the somatic compartment of NH2htau-expressing cultures. In mock-expressing cultures, LAMP1
showeda faint immunoreactivity and ahealthy anduniformly distributedTOM20-positivemitochondria networkwas evident. Scale bar: 10μm.Histograms show the analysis of LC3 autophagic
activity performedbyevaluation of the coefﬁcient of variation (CV=SD/mean) andof immunoﬂuorescence intensity alone or dividedby the area for LAMP-1 (pixel intensity andpixel intensity/
μm2; seeMaterials andmethods) between control- (white column) and NH2htau-infected neurons (black column). CVwas evaluated on cell bodieswhile the ﬂuorescence intensity represents
themean pixel intensity only in the vesicles. Values aremeans of three independent experiments and statistically signiﬁcant differences were calculated by unpaired-two tailed Student's t test
(*p b 0.05; **p b 0.01 versus mock). (B to F) The modulation in expression levels of p62/SQTM-1 (B), NBR1 (C) and LC3-II/LC3-I ratio (D), three key proteins involved in autophagosomes
formation, induced by neuronal transduction (MOI 25–50) with myc-NH2htau were evaluated by biochemical Western blotting on total protein extracts and relative densitometric analysis
(F). Densitometric quantiﬁcation of immunoreactivity levels was calculated by normalizing the values on the β-III tubulin intensity (E). Values are means of three independent experiments
and statistically signiﬁcant differenceswere calculated by unpaired-two tailed Student's t test (***pb0.0001 versusmock). (G to L)Western blotting analysis and relative densitometric analysis
(H–K), showing the difference in the intensity level of LC3-II in the absence and in the presence of baﬁlomycin A1 (BAF-A1, 50nM) and chloroquine (CQ 25 μM) for the last 6 h, by comparing
NH2htau-expressing neurons to control ones. Assessment of autophagic ﬂux calculated as the ratio of LC3II densitometric value of BAFA1- or CQ-treated samples over the corresponding un-
treated samples. Values are means of three independent experiments and statistically signiﬁcant differences were calculated by unpaired-two tailed Student's t test (**p b 0.01 versusmock
ormyc-NH2htau; ***pb 0.0001 versusmock). Representative immunoblot (n=3) for endogenous COXIVwas also shown (I) and relative densitometric analysis (L) was calculated by normal-
izing the values on the β-III tubulin intensity (J). Values aremeans of three independent experiments and statistically signiﬁcant differences were calculated by unpaired-two tailed Student's t
test (***p b 0.0001 versusmock; **p b 0.01 versusmyc-NH2htau).
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versus 4 comparedwith lane 2 versus1; Fig. 4H lane 6 versus4 compared
with lane 3 versus 1). The fact that the higher basal level in LC3II immu-
noreactivity was enhanced after lysosomal inhibition in NH2htau-
expressing neurons much more than in control clearly demonstrated
that an accelerated turnover of protein cargoes via autophagy occurred
in these cells (Fig. 4K). Importantly, an upregulation of COXIV immuno-
reactivity was also found in NH2htau-expressing cultures after inhibitor
treatment (Figs. 4I–L), supporting the notion that their elevated rate of
autophagic ﬂux was associated to a selective removal of mitochondria.
Collectively, these results point out that the increased intracellular
level of NH2htau fragment –as we found in vivo in AD mitochondria
(Amadoro et al., 2012)– is associated to selectivemitochondrial autoph-
agic clearance in neurons.
Mitochondrial quality control changes in NH2htau-expressing neurons in
correlation with the in vitro synaptic pathology
Themorphological aswell as functional impairment ofmitochondria
is crucial in synaptic demise occurring during the AD onset (Lee et al.,
2012b,; Du et al., 2010). A potential consequence of an unbalance of mi-
tochondria dynamics in neurons is indeed the failure to provide these
healthy organelles to sites of high-energy consumption, such as synap-
tic terminals, thus depriving of ATP and rendering themmore suscepti-
ble to reactive oxygen species (ROS) (Li et al., 2004). In addition,
mitochondria buffer calcium ions and its inefﬁcient handling can also
contribute to synaptic dysfunction and subsequently to “dying-
back” neurodegeneration (Calkins and Reddy, 2011; Nunnari and
Suomalainen, 2012; Reddy and Beal, 2005; Sheng and Cai, 2012). To in-
vestigate whether the morphological abnormalities of mitochondria
(i.e. reduced size and density) and their accumulation in the
somatoneuritic regions were accompanied to concomitant modiﬁca-
tions in synaptic domains, we assessed the expression level and distri-
bution of several speciﬁc pre- and post-synaptic markers in NH2htau-
transduced neurons, by Western blotting and immunocytochemistry
at 12 h post-infection. Consistently with that found in vivo in AD neu-
rons (Wang et al., 2009), the immunoreactivity of α-synuclein
(Fig. 5A), synaptosome-associated protein of 25 kDa (SNAP-25)
(Fig. 5B), synapsin I (Fig. 5C), synapthophysin (Fig. 5D) and PSD95
(Fig. 5E) signiﬁcantly decreased with the increasing MOI (25–50–
100). Densitometric quantiﬁcation of immunoreactivity level was
shown (Fig. 5G), by normalizing the values on the β-III tubulin
intensity (Fig. 5F). Accordingly, confocal microscopy showed that
NH2htau-infected cultures presented fewer and less immunoreac-
tive synaptic puncta if compared with control, mock-infected neu-
rons (Figs. 5H–I). Morphometric analysis (Figs. 5H–I) revealed a
signiﬁcant decline in the ﬂuorescent intensity and in the number of
synapsin-labeled (tau-infected versus mock-infected: 97% in intensity
and 88% in number; Student's t test *p b 0.05, **p b 0.01) and of
synapthophysin-positive buttons (tau-infected versus mock-infected:
98% in intensity and 299% in number; Student's t test **p b 0.01). Re-
markably and in agreement with our estimation of mtDNA content in
neuronal cultures (Fig. 1S) the full-length human myc-tau 1–441
(htau40) (Tolkovsky, 2009) –when expressed at similar low level
(MOI 50) of toxic NH2htau fragment (Fig. 5J)– did not alter the Pink-1
stability (Fig. 5K) and did not decrease the expression of p62/SQTM-1
(Fig. 5L) nor of OPA-1, VDAC1, cytC, α-synuclein and SNAP-25 (Figs.
5M–N–O–P–Q), as shown byWestern blotting analysis on total protein
extracts. These ﬁndings further corroborate the speciﬁc and potent
effect of neurotoxic NH2-truncated tau because the physiological form
of human tau was ineffective in perturbating the expression level of
proteins entailing with the mitochondrial autophagy (Figs. 5K–L–M–
N–O) as well as with the synapse stability (Figs. 5P–Q).
Altogether, these ﬁndings suggest that the dysfunction in quality
control of mitochondria induced by a speciﬁc enhanced level of
NH2htau fragment in cultured neurons is associated with pathologicalsynaptic alterations, as found in pathological AD conditions (Wang
et al., 2009).
Impairment in COX activity and increased ROS production also occur in
NH2htau-expressing neurons in correlation with pathological changes of
mitochondria dynamics
Changes in mitochondrial morphology can affect the mitochondrial
metabolism (Nunnari and Suomalainen, 2012; Sheng et al., 2012;
Trushina et al., 2012; Van Laar and Berman, 2013) and mitochondria
functions were reduced in AD brains almost in part owing to a loss of
their mass (Young-Collier et al., 2012) as well as in three FAD mouse
models (Trushina et al., 2012). Elongatedmitochondria display a higher
cristae density and then an enhanced efﬁciency of ATP synthase, which
sustains a more intense metabolic intracellular activity (Gomes et al.,
2011). In view of these ﬁndingswe quantiﬁed the variation of the respi-
ratory capacity in adenovirally-transduced cultures (MOI 50) by mea-
suring at 14 h post-infection a mitochondrial functional parameter,
such as cytochrome c oxidase (COX) activity which is commonly used
as an index of oxidative ability (Choubey et al., 2011; Wredenberg
et al., 2002). Fig. 6A reports the values found in total cell homogenates
(for details see Materials and methods) –obtained from mock– and
NH2htau-tranduced neurons, respectively. As shown, a signiﬁcant de-
crease of 33%, in COX activity (normalized by the total homogenate pro-
teins content), was found inNH2htau-infected cultureswhen compared
to control ones. Importantly, considering the mtDNA-derived CS
(Fig. 1R) as reliable marker of mitochondrial content, the ratio COX/CS
activity in NH2htau-expressing neurons (MOI 50) was quite different
from that of control ones (compare Fig. 6A to Fig. 1R), regardless of
the reduction in expression level of COXIV subunit protein (Fig. 1E).
Furthermore, a regulatory role for reactive oxygen species (ROS) of
mitochondrial origin as signaling molecules in selective autophagy has
been described (Scherz-Shouval and Elazar, 2007). Excessive oxidative
stress is inseparably linked to mitochondrial dysfunction in tau
transgenic mice and in ﬂies (David et al., 2005; Dias-Santagata
et al., 2007), as these organelles are both generators of and targets
for ROS (Lee et al., 2012a). Furthermore, one of the most important
non-enzymatic antioxidant defenses in neurons is the glutathione
(GSH) system which is in part localized in the mitochondrial matrix,
where it plays a key cellular role in counteracting the detrimental
effects elicited by an increased ROS production (Dasuri et al.,
2012). Therefore, as the glutathione disulﬁde (GSSG)/reduced gluta-
thione (GSH) ratio (GSH/GSSG ratio) is routinely used as an indicator
of the intracellular redox state levels, we decided to compare it between
mock- versus NH2htau-expressing cultures (MOI 50, 14 h) in order to
investigate whether an overproduction of ROS also occurred in these
neurons. As shown in Fig. 6B, a dramatic increase of 255% (normalized
by the total homogenate protein content) in GSSG/GSH ratio was
found in NH2htau-infected cultures in contrast to control ones, further
suggesting that their mitochondria were largely defective being source
of deleterious ROS.
Consistently with obvious ultrastructural changes (Fig. 1A) and in a
similar way of other pathogenetic proteins that are also localized to
mitochondria in different neurodegenerative human diseases, such as
Parkinson's Disease (PD)-associated A53Tα-synuclein (Choubey et al.,
2011; Nakamura et al., 2011) and DJ1 (Wang et al., 2012) and ALS-
linked mutant SODG93A (Magrané et al., 2012), these results demon-
strate that the NH2htau fragment impinges on themitochondrial oxida-
tive capacity and the antioxidant defense in neurons also by affecting
the quality control of mitochondria.
Discussion
The results we outline here provide evidence that the pathological
N-terminal truncation of human tau –which has known to be critically
involved in onset and progression of diverse human age-related
A)
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E)
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Fig. 5. Physiological full-length tau is ineffective in perturbating the expression level of proteins entailingwith themitochondrial autophagy as well aswith the synapses stability. (A to G)
Representative blots (A–G) of Western blotting analysis (n=3) on total protein extracts from hippocampal primary neurons (DIV 15) adenovirally transduced at increasing MOI
(25–50–100) with myc-NH2htau and withmock control (MOI 100) and examined at 12h post-infection. The intracellular levels of NH2htau down-regulates in a dose-dependent
manner (MOI 25–50–100) the immunoreactivity of pre-synaptic α-synuclein (A), synaptosome-associated protein of 25 kDa (SNAP-25) (B), synapsin I (C), synapthophysin (D)
and post-synaptic PSD95 (E). Densitometric quantiﬁcation of immunoreactivity level was shown (G), by normalizing the values on the β-III tubulin intensity (F). Values are
means of three independent experiments and statistically signiﬁcant differences were calculated by unpaired-two tailed Student's t test (*p b 0.05; ***p b 0.0001 versus
mock). (H–I) Representative images at 12 h post-infection (MOI 50) of synaptic structures labeled with synapsin (H) and synapthophysin (I) (red channel). Nuclei were stained
with DAPI (blue channel). A DIC (Differential Interference Contrast) light transmitted channel was acquired to visualize neuritic structures. Synapsin- and synapthophysin-labeled puncta
show amarked decrease of relative ﬂuorescence intensity and number inmyc-NH2htau-expressing hippocampal neurons compared to controls. Morphometric graphs conﬁrm as signif-
icant the detected differences in staining intensity and number of synapsin- and synapthophysin-positive dots between control (white column) and NH2htau-infected (black column)
cultures. Values are means of three independent experiments and statistically signiﬁcant differences were calculated by unpaired-two tailed Student's t test (*p b 0.05; **p b 0.01 versus
mock). Scale bar: 10μm. (J to R) Representative blots (J–Q)ofWestern blotting analysis (n=4) carried out on total protein extracts fromhippocampal primary neurons (DIV15) thatwere
adenovirus-mediated infected for 12 h with the full-length human myc-tau 1–441 (myc-htau) and with truncated myc-NH2htau (J) at similar low level (MOI 50). Control neurons were in-
fectedwithmock-vector aMOI 100 and collected at 12h asmyc-tagged-expressing cultures. The activation ofmitophagic pathway and synapses abundancewas compared in infected cultures,
by assessing the expression pattern of Pink-1 (K), p62/SQSTM1 (L), OPA-1 (M), VDAC1 (N), cytochrome c (O), α-synuclein (P), SNAP-25 (Q). β-III tubulin (R) was used ad loading control.
Values are means of three independent experiments and statistically signiﬁcant differences were calculated by unpaired-two tailed Student's t test (*p b 0.05; ***p b 0.0001 versusmock).
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we previously found to be increased in mitochondria from AD brains
(Amadoro et al., 2010, 2012)– associates to an impairment ofmitochondrial quality control in primary hippocampal neurons. By dif-
ferent and complementary experimental approaches, we report that
the toxic human NH2-truncated tau strongly affects the turnover of
Fig. 6. Impairment in COX activity and increased GSSG/GSH ratio are associated to alter-
ation of mitochondria turnover in NH2htau-expressing neurons. (A) Spectrophotometric
determination of mitochondria COX activity, measured by monitoring the decrease in
absorbance during the cyanide-sensitive oxidation of reduced form cytochrome cred
(10 μM), in the presence of 3 μM rotenone plus 0.8 μM antimycin A, and normalized by
the total homogenate proteins content, in total cell homogenates from mock-
and NH2htau-tranduced neurons (MOI 50) at 14 h post-infection (for detail see
Materials and methods). Absorbance decrease was recorded with a Jasco double
beam/double-wavelength spectrophotometer UV-550 at 548 nm–540 nm. Values
are means of ﬁve independent experiments and statistically signiﬁcant differences were
calculated byunpaired-two tailed Student's t test (***pb0.0001 versusmock). (B) Spectro-
photometric determination of the glutathione disulﬁde (GSSG)/Glutathione (GSH) ratio,
which measures the ROS-dependent-thiol oxidation state, in total cell homogenates
from mock- and NH2htau-tranduced neurons (MOI 50) at 14 h post-infection (for detail
see Materials and methods). Values are means of ﬁve independent experiments and sta-
tistically signiﬁcant differences were calculated by unpaired-two tailed Student's t test
(***p b 0.0001 versusmock).
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tween the accumulation of endogenous Parkin at these organelles and
severe perturbations in their turnover. Importantly, the early changes
of mitochondrial dynamics occur in dying neuronal cultures in concom-
itance to bioenergetic deﬁcits and synaptic damages. Taken together
and consistently with other papers reporting that unbalanced
mitophagy could be extremely deleterious in post-mitotic neurons
(Cheung and Ip, 2011; Wong et al., 2011a,b) and that pathological tau
can be per se a potent and direct upstream regulator of autophagy in
neurons (Inoue et al., 2012; Pacheco et al., 2009), our data suggest
that this pathogenetic form of NH2htau –in addition to its direct inhibi-
tory action on ANT-1 translocator (Amadoro et al., 2012; Bobba et al.,
2013)– may also affect in primary neurons the mitochondrial quality
control which, in turn, may critically impinge on their synapses.
Gain of function of tau protein and mitochondria quality control in
neurodegeneration
A potential role for abnormalities of mitochondria quality control in
tauopathies has been long put forward but the mechanisms by which
the over-expression of wild-type –as well as of mutant tau– inﬂuences
the size, shape and distribution of these organelles in neurons (Dixit
et al., 2008; Gilley et al., 2012; Stamer et al., 2002; Stoothoff et al.,
2009) and consequently the synapses (Chee et al., 2005; Thies and
Mandelkow, 2007) are still not ﬁnally known. We cannot completely
rule out that the proposed mechanisms (Dubey et al., 2008; Ittner
et al., 2009; Kanaan et al., 2011, 2012; Magnani et al., 2007) may con-
tribute to mislocalization of mitochondria into soma induced by the ex-
pression of MT-free NH2htau in neurons, but it is all the same possible
that this pathogenetic form of NH2-truncated tau can also inﬂuence
the distribution of these organelles by interfering with their dynamics,
likely through anomalous interactions with Parkin. We do favor this
possibility because Mfn2, a speciﬁc substrate of Parkin ubiquitination
(Gegg et al., 2010; Tanaka et al., 2010), is required for the movement
of mitochondria in neurons (Misko et al., 2010) and the activation of
Pink-1/Parkin pathway prevents the anterograde movement of these
organelles in order to quarantine them prior to autophagic clearance
(Kane and Youle, 2011; Liu et al., 2012; Wang et al., 2011). Besides, al-
though authors report that soluble P301L human tau adversely affects
the mitochondria distribution in rTg4510 mice in the absence of con-
comitant alterations in size of these organelles (Kopeikina et al.,
2011), our in vitro data are more in line with the in vivo AD conditions
in which a dramatic loss of inner cristae organization and of total mass
of mitochondria at synapses was retrieved in three different pre-
symptomatic FAD mice (Trushina et al., 2012) as well as in human
diseased specimens (Baloyannis, 2006; Chan, 2006; Hirai et al., 2001),
due almost in part to an increased autophagic removal (Moreira et al.,
2007a,b). Nevertheless, although mutant R406W tau was recently
reported to be able to induce an anomalous elongation of mitochondria
in ﬂies and in mouse neurons (Duboff et al., 2012), our in vitro study is
strengthened by the ﬁnding that the expression of another truncated
tau form (COOH-Asp-421) –which is more toxic to immortalized corti-
cal neurons when compared with a physiological full length human tau
isoform (htau40) in a similar way of the present NH2htau (Fig. 5)–
causes fragmentation and impairment of mitochondria (Quintanilla
et al., 2009, 2012). Accordingly, in our in vitro model, we also found
that the exogenous NH2htau drastically compromises the integrity of
these organelles that appeared more roundish, disorganized being
avoided of inner structures (Fig. 1A) and respiration-defective
(Figs. 2A, 6), just mirroring their excessive fragmentation described
to occur in post-mitotic neurons after APP overexpression or expo-
sure to oligomeric Aβ (Manczak et al., 2011; Wang et al., 2008b).
Finally, another recent work supports the notion that pathogenetic
tau can perturbate the quality control of neuronal mitochondria
in vivo showing that AD-like phosphorylated tau (AT8) physically in-
teracts in AD brains with the mitochondrial Drp1 and that its ﬁssion-linked GTPase activity was signiﬁcantly elevated in APP, APP/PS1 and
3XTg AD mice (Manczak and Reddy, 2012).Mitophagy in neurons: a question of balance
Compelling evidence has revealed that –although the normal elimi-
nation of defectivemitochondria is beneﬁcial playing a homeostatic and
neuroprotective role in neurons– it can cause “autophagic stress” if it is
excessive, inadequate or incomplete (Cheung and Ip, 2011;Wong et al.,
2011a,b). In fact, if mitophagic rate cannot be counterbalanced by an
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generative capacity of cellular protein synthesis, postmitotic neurons –
especially those suffering or aged– are no longer able to counteract it
and consequently the excessive autophagic demand inevitably commit
them to die (Wong et al., 2011a). On the other hand, limiting the
extreme autophagic/mitophagy response can allow neurons to success-
fully repair/regenerate a sufﬁcient pool of functional mitochondria and
then to survive (Zhu et al., 2012). In the present paper we show that
the toxic NH2htau-derived fragment triggers a marked depletion of a
large amount ofmitochondria in primary hippocampal neurons contrib-
uting thus to diminish their capacity for aerobic respiration, as yet de-
scribed for another protein involved in AD neurodegeneration such as
α-synuclein which also affects the activity of ANT-1 translocator
(Choubey et al., 2011; Nakamura et al., 2011; Xie and Chung, 2012). In
line with our in vitro data (Figs. 1, 2, 4, 6), Chakrabarti et al. (2009)
observed that a robust and indiscriminate upregulation of autophagy
takes place in Purkinje cell degeneration (PCD) transgenicmice, leading
to selective removal ofmitochondria in vivowhich is causally associated
with a severe neurodegenerative phenotype. Likewise, the overex-
pression of mutant PD-associated A53Tα-synuclein leads in primary
cortical neurons to a massive mitochondrial destruction, and then to
bioenergetic deﬁcits, which are both partially suppressed by overex-
pression of wtMfn2 as well as of dominant negative Drp1K38A or by
silencing in several autophagy-related genes, such as beclin 1 and
ATG12 (Choubey et al., 2011). Moreover, even though we do not
detect changes in beclin 1 levels in NH2htau-expressing neurons, as
reported by Choubey et al. (2011), a beclin-independent mitophagy
has been also described in neurons when acutely exposed to the
parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP+)
(Zhu et al., 2007). However, whether the in vitro genetic and/or
pharmacological inhibition of autophagy could offer a signiﬁcant
neuroprotection against the NH2htau-induced neuronal death and
whether the relocalization of Parkin to mitochondria is causally
involved in NH2htau-induced selective clearance of these organelles,
likely by a direct or indirect stable interaction with it, are all ques-
tions that at the moment are under our ongoing investigations. To
this regard, it's worthmentioning that recent studies have demonstrat-
ed that the knocking-down of Parkin by shRNA-encoding plasmids is
sufﬁcient per se to suppress the excessive mitophagy –and then to
provide partial neuroprotection– in A53Tsynuclein-expressing dopami-
nergic neurons (Choubey et al., 2011). The direct interaction between
endogenous Parkin and autophagic protein Ambra 1 (activating mole-
cule in Beclin 1-regulated autophagy) enhances in neurons the dynam-
ics and efﬁciency of Parkin-dependent clearance of mitochondria (Van
Humbeeck et al., 2011). Moreover, Parkin-null cortical neuronal/glial
cultures aremore resistant thanwild-type ones to toxicity of oligomeric
Aβ 1–42 (Solano et al., 2012) that, as well as the endogenous NH2htau
(Amadoro et al., 2010, 2012), targets and impairs mitochondria
(Manczak et al., 2011). Interestingly, our preliminary in vitro results
seem to be in line to these ﬁndings indicating that the viability as
well as the mitochondrial morphology and content are not affected
upon NH2htau overexpression in HeLa cells (Supplemental Fig. S2),
a human cervical cancer line which has little or no endogenous
Parkin expression (Denison et al., 2003; Pawlyk et al., 2003; Van
Humbeeck et al., 2011).
It is also worth mentioning that increasing evidence implicates the
cytosolic ubiquitin/proteasome system (UPS) as part of the quality con-
trol of mitochondria (Chan et al., 2011; Yoshii et al., 2011). Moreover, if
the proteasomal degradation actually promotes or inhibits the Parkin-
dependent mitophagy is still an unanswered question, especially in
view of the fact that post-mitotic primary neurons are more different
from cell-lines (Chan et al., 2011; Yoshii et al., 2011). Therefore, we do
not exclude the possibility that in our in vitro system Parkin could regu-
late themitochondrial turnover in both an autophagy-dependent and a
proteasome-dependentmanner but further experimentswill be needed
to clarify this important point.Finally, there are no doubts on the interplay between the bioener-
getic and mitochondrial dynamics to be uniquely and speciﬁcally regu-
lated in post-mitotic neurons (Cai et al., 2012; Van Laar et al., 2011).
Interestingly, to this regard it has been clearly demonstrated that
(i) the recruitment of Parkin tomitochondria is very slow in neurons,
unlike other cells, as it occurs only after 18–24 h CCCP treatment
while it is barely detectable at 12 h of depolarization (Cai et al.,
2012) –as in our in vitro experimental conditions– and (ii) the
rapid loss of ATP after a global mitochondrial insult may prevent in
neurons the full-scale Parkin-associated mitophagy, in comparison
to other non-neuronal glycolytic cells (Van Laar and Berman, 2013;
Van Laar et al., 2011).
Conclusions
In conclusion, in line with other papers referring that pathological
tau per se can affect the mitochondria quality control (Duboff et al.,
2012; Manczak and Reddy, 2012; Quintanilla et al., 2009, 2012) as
well as the autophagic pathway (Inoue et al., 2012; Pacheco et al.,
2009) and that an increased autophagic turnover of mitochondria was
detected in affected AD neurons (Young-Collier et al., 2012; Baloyannis,
2006; Moreira et al., 2007a,b), the present study further highlights the
critical role ofmitochondrial turnover control in ADpathogenesis show-
ing theNH2-truncation of human tau protein –whose levelwe previous-
ly found to be increased in mitochondria from AD brains (Amadoro
et al., 2010, 2012)– as a potential mediator in affecting it.
Materials and methods
Reagents and antibodies
Baﬁlomycin A1 (BAF-A1) B1793, chloroquine (CQ) C-6628, and FCCP
(carbonyl cyanide 4-(triﬂuoromethoxy)phenylhydrazone) C2759 were
from Sigma Aldrich. The following antibodies were used: α-synuclein
antibody mouse 610787 BD Transduction Laboratories; β-III tubulin
antibody rabbit ab18207 Abcam; kinesin antibody (clone IBII)
K1005 Sigma Aldrich; cytochrome C (136F3) rabbit 4280 Cell Signal-
ing Technology; cytochrome C antibody (clone 7H8.2C12) mouse
ab13575Abcam; COX IV antibody (clone 1D6E1A8) mouse ab14705
Abcam; p150 (Glued) antibody mouse 610473 BD Transduction
Laboratories; LAMP1 antibody (clone LY1C6) mouse VAM-EN001
Stressgen; LC3antibody rabbit PD014 MBL; LC3 antibody mouse
(clone 5F10) ALX-803-080 Enzo Life Sciences; Mfn2 antibody rabbit
M6444 Sigma Aldrich; c-Myc (9E10) antibody mouse sc-40 Santa
Cruz Biotechnology; c-Myc (A14) antibody rabbit sc-789 Santa
Cruz Biotechnology; OPA1 antibody mouse 612606 BD Transduction
Laboratories; Parkin antibody rabbit ab15954 Abcam; Parkin anti-
body mouse (clone Park8) P6248 Sigma-Aldrich; Pink-1 antibody
rabbit P0051 Sigma-Aldrich; Pink-1 antibody rabbit NB100-493
Novus Biologicals; PSD95 antibody rabbit 2507 Cell Signaling
Technology; SNAP 25 (synaptosome associated protein of 25 kDa,
C-terminal-speciﬁc) rabbit SL3730 Biomol International; synapsin I
antibody rabbit AB1543P Millipore Corporation; synaptophysin
antibody mouse VAM-SV011 Stressgen Biotechnologies; SOD II
(MnSOD, mitochondrial superoxide dismutase) rabbit SOD-110D
Stressgen Biotechnologies; mtHSP70 (Mitochondrial Heat Shock
Protein 70) mouse MA3-028 Afﬁnity Bioreagents; COXIV subunit I
mouse A6403 Molecular Probes; SQSTM1/p62 antibody rabbit
5114 Cell signaling; NBR1 antibody rabbit 5202 Cell signaling;
Tomm20 antibody rabbit (FL-145) sc-11415 Santa Cruz Biotech-
nology; ATPB antibody (3D5) mouse ab14730 Abcam; Drp1 anti-
body rabbit NB11055288 Novus Biological; Timm23 antibody
mouse 611222 BD transduction Laboratories; Mfn1 Antibody
mouse NBP1-71775 Novus Biologicals; anti-VDAC/Porin antibody
ab34726 Abcam; beclin-1 antibody mouse 3738 Cell Signaling;
phospho-DRP1 (Ser616) antibody 3455 Cell Signaling; anti-MFN2
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mthsp70 antibody rabbit 2816 Cell Signaling.Cell culture and treatments
SH-SY5Y human neuroblastoma cells (American Type culture Col-
lection, Rockville, MD, U.S.A.) were grown in DMEM/F12 medium
(Invitrogen, Gibco BRL 31331-028) supplemented with 10% fetal calf
serum (Invitrogen, Gibco BRL 10108-157), 100 U/ml of penicillin and
100 μg/ml of streptomycin (Invitrogen, Gibco BRL 15140-122) and
maintained at 37 °C in a saturated humidity atmosphere containing
95% air and 5% CO2. Naive cells at 20% conﬂuency were differentiated,
as we previously reported (Corsetti et al., 2008), by incubation for 5–
6 days in DMEM/F12 medium containing N2 (Invitrogen, Gibco BRL
17502-048), dbcAMP 1mM (Sigma-Aldrich, Oakville, Ontario, Canada-
D-0627) and NGF 100 ng/ml. For all treatments, the media with addi-
tives were changed after 1 and 3 days. Hippocampal neurons were
prepared from embryonic day 17–18 (E17/E18) embryos from timed
pregnant Wistar rats (Charles River), as we previously reported
(Amadoro et al., 2006, 2010). In detail, the hippocampus was dissected
out inHanks' balanced salt solution bufferedwithHEPES anddissociated
via trypsin/EDTA treatment. Cells were plated at 1×106 cells on 3.5-cm
dishes pre-coated with poly-DL-lysine. After 2 days of culturing in
neurobasal medium with B-27 supplement and glutamax, cytosine
arabinofuranoside was added to reduce glial proliferation. Half of the
medium was changed every 3–4 days and mature neuronal cultures
were infected at 15days in vitro, as reported in Amadoro et al. (2006).Assessment of neuronal viability
Cell viability was quantiﬁed by counting the number of intact nuclei,
after lysing in detergent-containing solution (Soto and Sonnenschein,
1985; Volontè et al., 1994) and by the MTT tetrazolium salt assay
(Manthorpe et al., 1986).Immunoﬂuorescence
Following treatment, neuronal cultureswerewashed twicewith PBS
and ﬁxed in PBS containing 4% (w/v) paraformaldehyde for 15min at
room temperature. Cells were washed with PBS 1× pH7.4 and perme-
abilized with 0.1% (v/v) Triton X-100/PBS pH7.4 for 4min at room tem-
perature. Coverslips were saturated with 2% BSA and 10% FCS in PBS 1×
for 3h followed by incubation overnight at 4°C in a humidiﬁed chamber
with primary antibody. Unbound antibody was removed by three
washes with PBS 1×. Bound antibody was detected by incubation
with donkey anti-rabbit Alexa 488 (1:500) and donkey anti-mouse rho-
damine-conjugated (1:500) secondary antibodies (Invitrogen) at room
temperature for 30 min. Nuclei were stained with 4,6-diamidino-2-
phenylindole dihydrochloride (DAPI; Sigma, St. Louis, MO, U.S.A.)
1:1000 in PBS for 10min. Controls were performed either by omitting
the primary antibody. For staining of mitochondria, MitoTracker red
CMxRos (M7512 Molecular Probes, Eugene, OR, USA) was added at a
concentration of 500nM and then incubated for 30min before ﬁxation
as standard procedures.Isolation of mitochondria
The mitochondrial extraction was performed using mitochondrial
extraction kit (Qiagen 37612), as previously described (Amadoro
et al., 2012). The purity of mitochondrial preparation was checked by
probing fractionated protein extracts with several speciﬁc antibod-
ies reacting with mitochondrial markers, as previously described
(Amadoro et al., 2012).Protein cellular lysate preparation
Total proteins were extracted by scraping the cells in an SDS-
reducing sample buffer or lysis in ice-cold RIPA buffer (50 mM Tris–
HCl pH8, 150mMNaCl, 1% Triton, 2mMEDTA, 0.1% SDS) plus proteases
inhibitor cocktail (Sigma Aldrich, P8340) and phosphatase inhibitor
cocktail (Sigma Aldrich, P5726/P2850) and centrifuged at 4 °C for
15min at 1000× g. The supernatant was then collected and boiled for
5 min. Proteins concentration was determined using the Bio-Rad RC
DC protein assay kit.
Western blot analysis and densitometry
Equal amounts of protein were subjected to SDS-PAGE 7.5–15%
linear gradient or Bis–Tris gel 4–12% (NuPage, Invitrogen). After
electroblotting onto a nitrocellulose membrane (Hybond-C Amersham
Biosciences, Piscataway, NJ) the ﬁlters were blocked in TBS containing
5% non-fat dried milk for 1 h at room temperature or overnight at
4 °C. Proteins were visualized using appropriate primary antibodies.
All primary antibodies were diluted in TBS and incubated with the
nitrocellulose blot overnight at 4 °C. Incubation with secondary peroxi-
dase coupled anti-mouse, anti-rabbit or anti-goat antibodies was per-
formed by using the ECL system (Amersham, Arlington Heights, IL,
U.S.A.) Final ﬁgures were assembled by using Adobe Photoshop 6 and
Adobe Illustrator 10 and quantitative analysis of acquired images was
performed by using ImageJ (http://imagej.nih.gov/ij/).
Confocal microscopy and image analysis
Slideswere examined under a confocal laser scanningmicroscope
(Leica SP5, Leica Microsystems, Wetzlar, Germany) equipped with 4
laser lines: violet diode emitting at 405 nm, argon emitting at
488nm, helium/neon emitting at 543nm, and helium/neon emitting
at 633 nm. In addition, a transmitted light detector for Differential
Interference Contrast (DIC; Nomarski) imaging was available. Confo-
cal acquisition setting was identical between control and experi-
mental cases. For production of ﬁgures, brightness and contrast of
images were adjusted and ﬁnal ﬁgures were assembled by using
Adobe Photoshop 6 and Adobe Illustrator 10. Image analysis was
performed by using Imaris Suite 7.4® (Bitplane A.G., Zurich,
Switzerland) or ImageJ 1.4 (imagej.nih.gov/ij/) softwares on ﬁve
different images derived from each experimental group. Image anal-
ysis was performed under visual control to determine thresholds
that subtracts background noise and takes into account neuronal
and mitochondrial structures. During image processing, the images
were compared with the original raw data to make sure that no
structures were introduced that were not seen in the original data
series or that structures present in the original data series were not
removed. To determine ﬂuorescent signal colocalization between
different channels a median ﬁlter was applied to the images, to re-
duce the background noise, and the degree of channels overlap was
characterized by Manders' and Pearson's coefﬁcients. To evaluate
the cell bodies and neuritic areas, their relative ﬂuorescence intensi-
ty, the mitochondria diameters and relative ﬂuorescence intensity,
two different masks were drawn on these two cellular domains by
using the light transmitted channel to visualize cell bodies and
neurites. After which the DAPI and light transmitted channels were
deleted and measures were performed by identifying mitochondria
as previously described (Colaço et al., 2012). Evaluation of synapse
ﬂuorescence intensity, diameters, numbers and of autophagic vesicle
ﬂuorescence intensity, diameters, numbers was performed on the all
image ﬁeld (130×130μm). Analysis of the neuritic network was per-
formed by using the ﬁlament tracer module and by considering the
average immunoﬂuorescent area and the average neuritic length.
To evaluate mitochondria fragmentation indexes images were proc-
essed using ImageJ software and plugins. Using a custom-written
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white) images by auto-thresholding, and mitochondrial particles
were analyzed for length (Major axis), width (minor axis), and
area:perimeter ratio as previously described (Dagda et al., 2009).
Analysis of autophagic activity was performed by evaluation of the
coefﬁcient of variation (CV; =SD/mean) for LC3 immunoﬂuores-
cence intensity in the neuronal cell bodies as previously described
(Campanella et al., 2009; Klionsky et al., 2012). Brieﬂy, with Imaris
software a mask was drawn on the cell bodies, as described above,
and the mean and SD were compared. Cells with increased levels of
autophagic activity, greater protein compartmentalization, greater
number of autophagosomes or autolysosomes in their cytosol,
show a CV higher. Conversely, in cells where autophagy is not occur-
ring, LC3 immunoﬂuorescence is uniformly distributed throughout
the cytosol and the CV is lower. Vesicle immunoﬂuorescence intensi-
ty was evaluated by ﬁltering the vesicles through thresholding based
on surface segmentation and background subtraction operated by
applying a local contrast algorithm. This procedure is able to detect
foci-like structures within a cell. LAMP1 immunoﬂuorescence evalu-
ation was performed only on positive vesicles-structures which
displayed a high variability in number, size and shape as previously
described (Falcón-Pérez et al., 2005). To take into account LAMP1
structure variability we adapted from this latter paper an analytical
strategy by considering the mean immunoﬂuorescence intensity di-
vided by the area of positive structures per cell.
Citrate synthase and cytochrome c oxidase assay
Citrate synthase (CS) and cytochrome c oxidase (COX) activities
were measured in cell homogenates. CS is a mitochondrial matrix en-
zyme which is part of the tricarboxylic acid cycle and whose activity is
frequently used as an index of the mitochondrial content (Fernández-
Vizarra et al., 2011; Kirby et al., 2007). COX activity was chosen as the
reference for the OXPHOS system activity, as this enzyme (complex
IV) constitutes the last step in the respiratory chain (RC) and it is,
most probably, limiting its electron ﬂux (Kunz et al., 2000; Mazat
et al., 2001). CS and COX activities weremeasured by spectrophotomet-
ric standard methods. Brieﬂy, measurements of CS activity were per-
formed using about 20–40 μg protein of total cell homogenate in a
ﬁnal volume of 2ml. The increase of the absorbance at 412nm (extinc-
tion coefﬁcient of 13.6 mM−1 cm−1) due to the formation of a yellow
complex of free CoA with DTNB was measured at 20 °C (Srere, 1968).
The CoA is formed in the reaction of acetyl-CoA with oxalacetate to
form citrate, catalyzed by CS. Absorbance change was recorded with a
Jasco double beam/double-wavelength spectrophotometer UV-550
and the rate of CoA formation, obtained as tangent to the initial parts
of the progress curves, was expressed as nmolmin−1mg−1 cell protein.
Complex IV, i.e. COX, was measured by recording the decrease in
absorbance during the cyanide-sensitive oxidation of 10 μM
ferrocytochrome c (reduced with substoichiometric concentrations
of potassium ascorbate) at 548–540 nm, in the presence of 3 μM
rotenone and 0.8 μM antimycin A (Atlante et al., 2008). Absorbance
change was recorded with a Jasco double beam/double-wavelength
spectrophotometer UV-550 and the rate of ferrocytochrome c oxida-
tion, obtained as tangent to the initial parts of the progress curves,
was expressed as nmol min−1mg−1 cell protein.
Glutathione disulﬁde/reduced glutathione ratio measurement
Glutathione (GSH) or glutathione disulﬁde (GSSG) was assayed in
cell homogenate, according to Atlante et al. (2003). Brieﬂy, GSH in the
presence of methylglyoxal (2mM) and glyoxalase I (6 e.u.) was specif-
ically converted into S-lactoyl-GSH which could be monitored directly
at 240nm;GSSG amountwas assayed in the same cuvette bymeasuring
the stoichiometric conversion of NADPH (10μM) spectrophotometrical-
ly at 340nm in the presence of glutathione reductase (1 e.u.).Transmission Electron Microscopy (TEM)
Cells were grown on coverslips in the same conditions previously
used for optical microscopy. The coverslip was removed from the cells
layer by immersion in liquid nitrogen after resin polymerization at
warm temperature (60 °C). After a brief rinse in PBS, cells attached to
a glass surface were ﬁxed with 2.5% glutaraldehyde in 0.1M phosphate
buffer, pH 7.3, for 10min at room temperature and then for 20min at
4 °C. Cells were then rinsed in 0.1M phosphate buffer, pH7.3, postﬁxed
with 1% osmium tetroxide in the same buffer for 1 h at 4 °C then
dehydrated in ascending alcohols, and ﬁnally treated with propylene
oxide. After embedding in Araldite (Electron Microscopy Sciences, Ft.
Washington, PA), ultrathin section was cut with a Reichert OMultrami-
crotome. Sections were stained with uranyl and lead citrate, and then
examined with a Transmission Electron Microscope Jeol model 100S
(JEOL, Peabody, MA) operated at 80 kV. Images were contrasted by
using the ImageJ plugin CLAHE (Contrast Limited Adaptive Histogram
Equalization) ﬁlter which enhances the contrast of grayscale images.
Figures were prepared by using Adobe Illustrator 10.
Mitochondrial DNA content
Mitochondrial DNA content (mtDNA) was measured as described in
Fu et al. (2008). Brieﬂy, neuronal cell line SH-SY5Y cells were infected as
described in the text. After 12h post-infection, cells were washed twice
with PBS and DNA was prepared by lysing cells in 1mM EDTA, 10mM
Tris, pH 8.0, 1% SDS, followed by denaturation at 95 °C for 20min and
a 25-fold dilution in water. Four microliters of the diluted cell lysates
was used for Real Time PCR. Mitochondrial DNA was quantiﬁed by
measuring content of a speciﬁc mitochondrial gene NADH-ubiquinone
oxidoreductase chain 2 (mtND2). Human-Telomerase Reverse Tran-
scriptase (hTERT) DNA was used as the internal control. The quantita-
tive Real Time PCR reaction was carried out in a total volume of 20 μl
using Sensimix SYBR-Green (Bioline) following the manufacturer's
instructions. The gene speciﬁc primers utilized were: MT ND2 left:
5′-ctaccgcattcctactactcaactt-3′; MT ND2 right: 5′-ggtggatggaattaa
gggtgt-3′; hTERT left: 5′-ccctcctttgccttccac-3′; and hTERT right: 5′-agct
cccagggtccttctc-3′. Sequence-speciﬁc ampliﬁcation was detected on
the ABI Prism 7900 sequence detection system (Applied Biosystems).
Statistical analysis
Experiments were carried out in triplicates and repeated at least
three times. Data were expressed as means± SD (n= 4). Statistically
signiﬁcant differenceswere calculated by unpaired-two tailed Student's
t test (*p b 0.05; **p b 0.01; ***p b 0.0001) as indicted in the ﬁgure
legends. For Western blot analysis and immunoﬂuorescence studies
shown were representative of at least three separate experiments.
Relative differenceswere expressed as percentage change andwere cal-
culated as (Exp−CTRL)/Exp×100.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nbd.2013.10.018.
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